-
Assessment and Follow-Up of the Aortic Root by 2-Dimensional Echocardiography Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-09 James L. Vacek MD MS
-
Impact of Tricuspid Regurgitation on Outcomes After Transcatheter Mitral Valve Replacement Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-09 Hiroki A. Ueyama MD, Giancarlo Licitra MD, Patrick T. Gleason MD, Omid Behbahani-Nejad MD, Roshan Modi BS, Dhiren Rajagopal, Isida Byku MD, Joe X. Xie MD, Adam B. Greenbaum MD, Gaetano Paone MD, W. Brent Keeling MD, Kendra J. Grubb MD, George S. Hanzel MD, Chandan M. Devireddy MD, Peter C. Block MD, Vasilis C. Babaliaros MD
Development of functional tricuspid regurgitation (TR) because of chronic mitral disease and subsequent heart failure is common. However, the effect of TR on clinical outcomes after transcatheter mitral valve replacement (TMVR) remains unclear. We aimed to evaluate the impact of baseline TR on outcomes after TMVR. This was a single-center, retrospective analysis of patients who received valve-in-valve
-
Outcomes After Left Atrial Appendage Clip Placement During Cardiac Surgery: A Nationwide Analysis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-05 Jean-Luc A. Maigrot BS, Aaron J. Weiss MD PhD, Guangjin Zhou PhD, Haley N. Jenkins MD, Siran M. Koroukian PhD, Krish C. Dewan MD, Edward G. Soltesz MD MPH
This study evaluated the nationwide associations between concomitant left atrial appendage clip (LAAC) placement during cardiac surgery and postoperative outcomes. We identified 1,260,999 patients who underwent coronary artery bypass grafting, valve, and aortic surgeries in the 2016 to 2020 Nationwide Readmissions Database and stratified by concomitant LAAC versus no LAAC placement. Patients who underwent
-
Immediate Versus Staged Complete Revascularization in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-04 Huzaifa Ahmad Cheema MBBS, Karan Bhanushali MD, Aruba Sohail MBBS, Areej Fatima MD, Alaa Hamza Hermis RN PhD, Anoop Titus MD, Adeel Ahmad MD, Vidit Majmundar MD, Wajeeh Ur Rehman MD, Samian Sulaiman MD, Vladimir Lakhter DO, Suzanne J. Baron MD MSc, Sourbha S. Dani MD MSc
A strategy of complete revascularization (CR) is recommended in patients with acute coronary syndrome (ACS) and multivessel disease (MVD). However, the optimal timing of CR remains equivocal. We searched MEDLINE, Embase, the Cochrane Library, and for randomized controlled trials (RCTs) comparing immediate CR (ICR) with staged CR in patients with ACS and MVD. Our primary outcomes were all-cause and
-
Acute Coronary Syndrome Revascularization Strategies With Multivessel Coronary Artery Disease Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-04 R. Jay Widmer MD PhD, Kendall Hammonds MPH, Timothy Mixon MD, Jose Emilio Exaire MD, Christopher Douglas Chiles MD, Giuseppe Tavilla MD PhD, Molly I. Szerlip MD, J. Michael DiMaio MD
In acute coronary syndromes (ACS), revascularization is the standard of care. However, trials comparing contemporary coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are limited. Optimal revascularization in patients with multivessel coronary artery disease (MV-CAD) presenting with ACS is unclear. This is a multicentered, retrospective observational study from a large
-
Aortic Regurgitation, Time to Aortic Valve Reintervention, and Mortality in Degenerated Trifecta Versus Non-Trifecta Bioprosthesis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-04 Amr E. Abbas MD, Luai Madanat MD, Houman Khalili MD, Ramy Mando MD, Mazhed Kheyrbek MD, Rohit Chandra MD, Shailesh Niroula MD, Ivan Hanson MD, Simon Dixon MD, Brian Renard MD, Richard Bloomingdale MD, Elvis Cami MD, Brittany Pridham NP, Jeffrey Altshuler MD, Bogdan Kindzelski MD, Franco Fazzalari MD, Francis Shannon MD, Alessandro Vivacqua MD
On July 31, 2023, the Trifecta valve was withdrawn from the market after concerns regarding early (≤5 years) structural valve deterioration (SVD), mainly as aortic regurgitation (AR). Our aim was to determine the timing, mechanism, and impact of bioprosthetic SVD in patients who underwent redo aortic valve replacement (redo-AVR) with either redo-SAVR or valve-in-valve transcatheter aortic valve replacement
-
Causes and Clinical Outcomes of Patients Who Failed Screening for Transcatheter Tricuspid Valve Interventions Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-04 Ghadi Moubarak MD, Austin Kluis MD, John Eisenga MD, Kyle McCullough MD, Jonathan Ladner BS, Mohammed Salih MD, Jasjit Banwait PhD, J. Michael DiMaio MD, Michael J. Mack MD, Timothy George MD, Molly I. Szerlip MD
Transcatheter tricuspid valve intervention (TTVI) has recently emerged as a promising alternative to surgery for tricuspid regurgitation (TR). However, a significant proportion of patients fail screening for TTVI, and little is known about their characteristics and natural history. This study sought to investigate causes of screen failure and outcomes of patients declined for TTVI. This was a retrospective
-
Stepping Away from the Monolith: The Disaggregation of Asian Cardiovascular Data Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-04 Shruti Revankar MD, Anandita Agarwala MD
-
Convolutional Neural Networks to Study Contrast-Enhanced Magnetic Resonance Imaging–Based Skeletal Calf Muscle Perfusion in Peripheral Artery Disease Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-03 Bijen Khagi PhD, Tatiana Belousova MD, Christina M. Short MBA, Addison A. Taylor MD PhD, Jean Bismuth MD, Dipan J. Shah MD, Gerd Brunner MS PhD
Peripheral artery disease (PAD) is associated with impaired blood flow in the lower extremities and histopathologic changes of the skeletal calf muscles, resulting in abnormal microvascular perfusion. We studied the use of convolution neural networks (CNNs) to differentiate patients with PAD from matched controls using perfusion pattern features from contrast-enhanced magnetic resonance imaging (CE-MRI)
-
Trainee Perceptions of Off-Pump Coronary Artery Bypass Grafting: United Kingdom Training Needs Survey Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-03 Maria Comanici MD, Manish Soni MBBS, Shahzad G. Raja BSc MBBS (Hons)
-
Prophylactic Treatment to Prevent Left Ventricular Thrombus After Anterior Myocardial Infarction Treated With Primary Percutaneous Intervention Am. J. Cardiol. (IF 2.8) Pub Date : 2024-04-03 Shannon L. Clay MD, James C. Blankenship MD MHCM
-
PRECISE-DAPT, ARC-HBR, or Simplified Clinical Evaluation for the Prediction of Major Bleeding After Percutaneous Coronary Intervention in older Patients Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-28 Alexander Felix Marschall MD, Juan Duarte Torres MD, Belén Biscotti Rodíl MD, Inés Gómez Sánchez MD, Elena Basabe Velasco MD, Carmen Ramos Alejos-Pita MD, Edurne López Soberón MD, Alfonso Suárez Cuervo MD, Salvador Álvarez Antón MD, Jose María de la Torre Hernández MD PhD, David Martí Sánchez MD PhD
Older patients have been remarkably underrepresented in bleeding risk cohorts. Thus, the PRECISE-DAPT (Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy) and Academic Research Consortium for High Bleeding Risk (ARC-HBR) scores are not validated in older adults. Therefore, we sought to evaluate the PRECISE-DAPT
-
-
It Is Time to Overcome the “One-Size-Fits-All” Approach in Chronic Coronary Syndrome? Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-27 Giampaolo Niccoli MD PhD, Filippo Luca Gurgoglione MD
-
Aspirin for Primary Prevention in Patients With Elevated Coronary Artery Calcium Score: A Systematic Review of Current Evidences Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-26 Apoorva Doshi MBBS, Haresh Gandhi MD, Kunal N. Patel MD MPH, Monil Majmundar MD, Rajkumar Doshi MD MPH
The 2019 American College of Cardiology and American Heart Association guidelines regarding low-dose aspirin in the primary prevention of atherosclerotic cardiovascular disease (ASCVD) indicate an increased risk of bleeding without a net benefit. The coronary artery calcium (CAC) score could be used to guide aspirin therapy in high-risk patients without an increased risk of bleeding. With this systematic
-
Lower Oral Anticoagulant Prescribing for Atrial Fibrillation in Women Compared With Men Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-26 Veena Manja MBBS MSc PhD, Ciaran S. Phibbs PhD, Lakshmi Ananth MS, Fay Saechao MPH, Susan M. Frayne MD
-
Comparison of Postprocedural P-Wave Vector Magnitude on 12-Lead Electrocardiogram Between Cryoballoon and Radiofrequency Ablation Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-24 Masamichi Yano MD PhD, Yasuyuki Egami MD, Shodai Kawanami MD, Kohei Ukita MD, Akito Kawamura MD, Koji Yasumoto MD, Masaki Tsuda MD, Naotaka Okamoto MD, Yasuharu Matsunaga-Lee MD, Masami Nishino MD PhD
Pulmonary vein isolation (PVI) causes changes in P-wave parameters. However, the difference in changes in P-wave parameters including P-wave vector magnitude (Pvm) between radiofrequency catheter ablation (RFCA) and cryoballoon ablation (CBA) remains unknown. Paroxysmal atrial fibrillation (PAF) patients who underwent only PVI were enrolled. Pvm was calculated by the square root of the sum of the squared
-
10-Year Mortality of Off-Pump Versus On-Pump Coronary Artery Bypass Grafting: An Updated Systematic Review, Meta-Analysis, and Meta-Regression Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-24 Maria Comanici MD, Halil Ibrahim Bulut, Shahzad Gull Raja BSc MBBS
The longstanding debate on off-pump coronary artery bypass grafting (OPCAB) versus on-pump coronary artery bypass grafting (ONCAB) has primarily focused on short-term and mid-term outcomes, with limited attention to long-term survival. This study aims to address this gap by providing an updated analysis of 10-year mortality rates after OPCAB versus ONCAB.
-
Off-Pump Coronary Artery Bypass Grafting Does Not Confer Superior Outcomes Among Frail Patients Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-23 Sara Sakowitz MS MPH, Syed Shahyan Bakhtiyar MD MBE, Joanna Curry BA, Saad Mallick MD, Amulya Vadlakonda BS, Konmal Ali, Yas Sanaiha MD, Peyman Benharash MD
Off-pump coronary revascularization (OPCAB) has been proposed to benefit patients who are at a greater surgical risk because it avoids the use of extracorporeal circulation. Although, historically, older patients were considered high-risk candidates, recent studies implicate frailty as a more comprehensive measure of perioperative fitness. Yet, the outcomes of OPCAB in frail patients have not been
-
Time to Tweak the Definition of Type 2 Myocardial Infarction Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-23 John A. Ambrose MD, Richard Kiel MD, Asseel AlBayati MD
-
Relation of Vasoreactivity in the Left and Right Coronary Arteries During Acetylcholine Spasm Provocation Testing Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-22 Yoshiyuki Okuya MD, Yuichi Saito MD, Hideki Kitahara MD, Yoshio Kobayashi MD
The diagnosis of vasospastic angina (VSA) according to Japanese guidelines involves an initial intracoronary acetylcholine (ACh) provocation test in the left coronary artery (LCA) followed by testing in the right coronary artery (RCA). However, global variations in test protocols often lead to the omission of ACh provocation in the RCA, potentially resulting in the underdiagnosis of VSA. This study
-
Prognosis Impact and Prediction of Trans-Radial Access Failure in Patients With STEMI, A Nationwide Observational Study Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-21 Dániel Tornyos MD, Réka Lukács MD, András Jánosi MD DSc, András Komócsi MD DSc
-
Impaired Culprit-Vessel Flow Affects Percutaneous Coronary Intervention Outcomes in Spontaneous Coronary Artery Dissections Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-16 Stefano Benenati MD, Federico Giacobbe MD, Fernando Macaya MD PhD, Giuseppe Patti MD, Giuseppe Musumeci MD, Nieves Gonzalo MD PhD, Javier Escaned MD PhD, Ferdinando Varbella MD, Enrico Cerrato MD PhD, Italo Porto MD PhD, DISCO Collaborators
-
A Comparison of Ultrathin Struts Drug-Eluting Stents Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-15 Vernon V.S. Bonarjee MD PhD
-
Gender Differences in the Short and Long-Term Outcomes Following Rotational Atherectomy: A Meta-Analysis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-14 Song Peng Ang MD, Chayakrit Krittanawong MD FACC, Muhammed Haris Usman MD FACC, Jose Iglesias DO, Jia Ee Chia MD, Kanan Jahangirli MD, Temitope Akinyemi MD, Debabrata Mukherjee MD FACC MSCAI
Rotational atherectomy (RA) is used to address complex calcified coronary lesions but data regarding the association between gender and outcomes of patients who underwent RA remain uncertain. We aimed to investigate the short- and long-term outcomes of patients who underwent RA based on gender.
-
Intracoronary Near-Infrared Spectroscopy to Predict No-Reflow Phenomenon During Percutaneous Coronary Intervention in Acute Coronary Syndrome Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-13 Yuichi Ozaki MD PhD, Hironori Kitabata MD PhD, Masahiro Takahata MD PhD, Yosuke Katayama MD PhD, Teruaki Wada MD PhD, Ryo Hikida MD, Akira Taruya MD PhD, Yasutsugu Shiono MD PhD, Akio Kuroi MD PhD, Takashi Yamano MD PhD, Takashi Tanimoto MD PhD, Atsushi Tanaka MD PhD
Near-infrared spectroscopy-intravascular ultrasound (NIRS-IVUS) can identify the lipid-rich lesions, described as high lipid-core burden index (LCBI). The aim of this study was to investigate the relation between lipid-core plaque (LCP) in the infarct-related lesion detected using NIRS-IVUS and no-reflow phenomenon during percutaneous coronary intervention (PCI) in patients with acute coronary syndrome
-
Coronary Calcification Optical Coherence Tomography—Another Brick in the Wall Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-13 Owais S. Abdul-Kafi MD, Mladen I. Vidovich MD
-
Alternative Approaches for Alcohol Septal Ablation in Hypertrophic Cardiomyopathy: The Call for a Personalized Treatment Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-13 Francesco Pelliccia MD PhD, Elisabetta Moscarella MD PhD, Paolo Calabrò MD PhD, Giuseppe Andò MD PhD
-
Atrial Functional Substrates for the Prediction of Atrial Fibrillation Recurrence After Pulmonary Vein Isolation Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-12 Masaharu Masuda MD PhD, Yasuhiro Matsuda MD, Hiroyuki Uematsu MD, Mitsutoshi Asai MD PhD, Shin Okamoto MD, Takayuki Ishihara MD, Kiyonori Nanto MD, Takuya Tsujimura MD, Yosuke Hata MD, Naoko Higashino MD, Sho Nakao MD, Toshiaki Mano MD PhD
-
Cardiovascular Complications in Young Adults With Postacute Sequelae of COVID-19: A Perspective from the United States Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-11 Jasninder Singh Dhaliwal MD, Nomesh Kumar MD, Sebastian Mactaggart MBBS, Hemamalini Sakthivel MD, Raheel Ahmed MBBS MRCP PGCME, Renuka Verma MD, Kamleshun Ramphul MD
-
Heart Rate at Rest and Incident Atrial Fibrillation in Patients With Diastolic Dysfunction Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-09 Stefan Preisendörfer MD, Virginia Singla MD, Aditya Bhonsale MD, Krishna Kancharla MD, Floyd Thoma BS, Suresh Mulukutla MD, Andrew Voigt MD, Alaa Shalaby MD, N.A. Mark Estes MD, Sandeep Jain MD, Samir Saba MD
Diastolic dysfunction (DD) is associated with incident atrial fibrillation (AF). The influence of heart rate at rest (RHR) on incident AF in patients with DD has not been investigated. The goal of this study is to assess the influence of RHR on incident AF in patients with DD. Patients from a large health system with no previous history of AF, a left ventricular ejection fraction ≥50%, and documented
-
-
More Than Meets the Eye: Defining the Prevalence, Pathophysiology, and Approach to Myocardial Iron Overload Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-08 Lauren K. Truby MD MS, Katherine Michelis MD, Justin L. Grodin MD MPH
-
Is Platelet Reactivity Testing in Patients With Peripheral Arterial Disease Who Underwent Endovascular Therapies Ready for Routine Clinical Use? Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-07 Madhan Shanmugasundaram MD
-
Prospective, Multi-center, Single-Arm Study of the Auryon Laser System for Treatment of Below-the-Knee Arteries in Patients With Chronic Limb-Threatening Ischemia: 30-Day Results of the Auryon BTK Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-07 Nicolas W. Shammas MD MS, Timothy Yates MD, Ashwani Sastry MD, Joseph Ricotta MD, Robert Beasley MD, Warren Swee MD, James T. Torey PA-C, Gail A Shammas BSN RN, Sue Jones-Miller MS, Michele Corbet MS
The 355 nm Auryon laser (AngioDynamics, Inc., Latham, New York) has been shown to be effective and safe in treating various morphology lesions in the femoropopliteal arteries. There are limited data on the Auryon laser in treating below-the-knee (BTK) arteries in patients with chronic limb-threatening ischemia. We present the 30-day efficacy and safety findings from the ongoing Auryon BTK study. Patients
-
Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-07 Federica Troisi MD PhD, Pietro Guida PhD, Nicola Vitulano MD, Federico Quadrini MD, Antonio Di Monaco MD, Giuseppe Patti MD, Massimo Grimaldi MD PhD
Left atrial or left atrial appendage thrombosis (LAT) is contraindicated for cardiac ablation (CA) or cardioversion (CV) of atrial fibrillation (AF). This study was aimed to compare the frequency of LAT detected by transesophageal echocardiography (TEE) before CA or CV in patients with AF treated with direct oral anticoagulants (DOACs) or vitamin K antagonists (VKAs). We searched PubMed, Scopus, Web
-
Unveiling the Hidden Stroke Threat in Patients With Atrial Fibrillation and Primary Hyperparathyroidism Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Georges Khattar MD, Samer Asmar MD, Elie Bou Sanayeh MD MBA, Praneeth Keesari MD, Wissam Rahi MD, Fouad Sakr MD, Michel Khoury MD, Michael Cinelli DO, Samantha Lee MD, Mitchell Weinberg MD MBA, Marcin Kowalski MD MBA, Valay Parikh MD
Recent American College of Cardiology (ACC), American Heart Association (AHA), American College of Clinical Pharmacy (ACCP), and Heart Rhythm Society (HRS) guidelines suggest that patients with atrial fibrillation (AF) at intermediate to low annual risk of ischemic stroke can benefit from consideration of factors that might modify their risk of stroke. The role of nontraditional risk factors, such
-
Association of Serum Homocysteine With Peripheral Arterial Disease in Patients Without Diabetes: A Study Based on National Health and Nutrition Examination Survey Database Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Yi You MM, Naxin Zeng BS, Wengao Wu MM, Boyang Liu MM, Sheng Rong MM, Dong Xu MM
This study aimed to investigate the association of serum homocysteine (Hcy) levels with peripheral arterial disease (PAD) in patients without diabetes on the basis of data from the National Health and Nutrition Examination Survey. The study used data from 3 survey cycles (1999 to 2004) in the National Health and Nutrition Examination Survey database as the research dataset. Serum Hcy levels were considered
-
A Curious Case of Left Ventricular Outflow Tract Velocity Time Integral Alternans With an Intra-Aortic Balloon Pump: Physiology in Action Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Sumana Vardhan MD, Jonathan D. Moreno MD PhD
-
Nature of Neurological Complications and Outcome After Surgery for Type A Aortic Dissection Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Fausto Biancari MD PhD, Francesco Onorati MD PhD, Sven Peterss MD, Joscha Buech MD, Giovanni Mariscalco MD PhD, Javier Rodriguez Lega MD, Angel G. Pinto MD, Antonio Fiore MD PhD, Andrea Perrotti MD PhD, Amelié Hérve MD, Andreas Rukosujew MD, Till Demal MD, Lenard Conradi MD PhD, Konrad Wisniewski MD, Marek Pol MD, Petr Kacer MD, Giuseppe Gatti MD, Enzo Mazzaro MD, Igor Vendramin MD PhD, Daniela Piani
Surgery for type A aortic dissection (TAAD) is frequently complicated by neurologic complications. The prognostic impact of neurologic complications of different nature has been investigated in this study. The subjects of this analysis were 3,902 patients who underwent surgery for acute TAAD from the multicenter European Registry of Type A Aortic Dissection (ERTAAD). During the index hospitalization
-
The burden of psychological trauma and post-traumatic stress disorder among adults with congenital heart disease: PTSD in ACHD Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 David J. Harrison MD, Joseph Kay MD, Roni M. Jacobsen MD, Camila Londono-Obregon MD, Elizabeth Yeung MD, Sarah L. Kelly PsyD, Ann Poteet NP MS, Claire Levek MS, Michael J. Landzberg MD, Molly Wallrich RN, Amber Khanna MD
Psychological trauma, symptoms of post-traumatic stress disorder (PTSD), and mental health conditions are common in adult congenital heart disease (ACHD). There is a gap in research examining PTSD in ACHD using the current Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria in assessing patient characteristics and experiences with trauma-focused treatment.
-
Aortic Root Dimension Using Transthoracic Echocardiography: Results from the Copenhagen City Heart Study Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-06 Maria W. Pedersen PhD, Kirsten Duch cand. Scient, Filip L. Lindgren MD, Nils L.O. Lundgren MD, Bhupendar Tayal PhD, Andreas Hagendorff MD, Gorm B. Jensen DMSc, Tor Biering-Sørensen PhD, Peter Schnohr DMSc, Rasmus Møgelvang PhD, Nis Høst PhD, Kristian Kragholm PhD, Niels H. Andersen DMSc, Peter Søgaard DMSc
Findings regarding the relation between aortic size and risk factors are heterogeneous. This study aimed to generate new insights from a population-based adult cohort on aortic root dimensions and their association with age, anthropometric measures, and cardiac risk factors and evaluate the incidence of acute aortic events. Participants from the fifth examination round of the Copenhagen City Heart
-
Contribution of Peripheral Microvascular Dysfunction to Mild Cognitive Impairment Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-05 Matthew E. Gold MD, Steven C. Rogers MD PhD, Ambar Kulshreshtha MD PhD, Yuxuan Chen BS, Yi-An Ko PhD, Michael L. Cheng MD, Daniel A. Gold MD, Nishant Vatsa MD, Vardhmaan Jain MD, Shivang Desai MD, Kasra Moazzami MD MPH MSCR, Tiffany Thomas MS, Maureen Okafor MD MPH, Felicia Goldstein PhD, James Lah MD PhD, Arshed A. Quyyumi MD, Ihab Hajjar MD MPH
-
Associations Between Metabolic Syndrome and Long-Term Mortality in Patients who underwent Percutaneous Coronary Intervention: An Australian Cohort Analysis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-04 Joseph M. O'Brien MBBS, Diem Dinh BAppSc PhD, Louise Roberts BSc PhD, Andrew Teh MBBS PhD, Angela Brennan RN, Stephen J. Duffy MBBS PhD, David Clark MBBS DMedSci, Andrew Ajani MBBS MD, Ernesto Oqueli MD, Martin Sebastian MBBS, Christopher Reid BA DipEd MSc, Cert Health Econ PhD, Melanie Freeman MBBS, Jaya Chandrasekhar MBBS MS PhD, Melbourne Interventional Group
Metabolic syndrome (MetS) provides significant risk for coronary disease, however long-term prognosis after percutaneous coronary intervention (PCI) has been understudied. We assessed the prevalence and outcomes of patients with MetS from an Australian PCI cohort. We retrospectively examined data from the Melbourne Interventional Group multicenter PCI registry using a modified definition for MetS including
-
SYNERGY- Everolimus eluting stent with a bioabsorbable polymer in ST elevation myocardial infarction- CLEAR SYNERGY OASIS-9 Registry Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-04 Sanjit S. Jolly MD, Shun Fu Lee PhD, Rajibul Mian PhD, Sasko Kedev MD, Shahar Lavi MD, Raul Moreno MD, Gilles Montalescot MD, Ali Hillani MD, Timothy D. Henry MD, Valon Asani MD, Robert F. Storey MD, Johanne Silvain MD, James C.S. Spratt MD, Marc-André d'Entremont MD, Goran Stankovic MD, Biljana Zafirovska MD, Madhu K. Natarajan MD, Manel Sabate MD, Satya Shreenivas MD, Natalia Pinilla-Echeverri MD
Our objective was to evaluate the clinical effectiveness of the SYNERGY stent in patients with ST elevation myocardial infarction (STEMI). The only drug eluting stent approved for treatment of STEMI by the FDA is the Taxus stent which is no longer commercially available, so further data are needed. The CLEAR SYNERGY stent registry was embedded into a larger randomized trial of patients with STEMI (N=7000)
-
Sustainability of Blood Pressure Reduction Through Adapted Mindfulness Training: The MB-BP Study Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-04 Eric B. Loucks PhD, Vinicius V. Neves MD MSc, Virginia Cafferky BS, Matthew M. Scarpaci MPH, Ian M. Kronish MD MPH
-
Distal versus Proximal Radial Artery Access for Cardiac Catheterization: 1-year Outcomes Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Karim Al-Azizi MD, Ghadi Moubarak MD, Chadi Dib MD, Sameh Sayfo MD, Molly Szerlip MD, Sibi Thomas DO, Sarah Hale BA, Johanna Van Zyl PhD, Richard M. Settele BS, Osniel Ramos Gonzalez BS, Stephanie J. Ventura BA, J. Michael DiMaio MD, Michael J. Mack MD, Srinivasa Potluri MD
PRA access for cardiac catheterization is safe but can jeopardize subsequent use of the artery due to occlusion. DRA access in the anatomical snuffbox preserves the RA but safety and potential detrimental effects on hand function are unknown. We aimed to assess hand function and complications post Distal radial artery (DRA) and Proximal radial artery (PRA).
-
Distal Versus Proximal Radial Arterial Access for Percutaneous Coronary Angiography and Intervention: Updated Meta-Analysis of Randomized Controlled Trials Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Syed Hamza Mufarrih MD, Sajjad Haider MD, Nada Qaisar Qureshi MD, Mohammad Saud Khan MD, Mohammed Kazimuddin MD, Muhammad Shoaib Akbar MD, Sameer Saleem MD, Syeda Aleena Mufarrih MD, Avnish Tripathi MD MPH PhD, Aniruddha Singh MD, Mohammad Abdul Waheed MD
-
Etiologies and Impact of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High-Volume Quaternary Care Hospital Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Lu Chen MD, Lin Wang MD MS, George Petrossian MD, Newell Robinson MD, William Chung MD, Matthew Henry MD, Dennis Mihalatos MD, Ruqiyya Bano MPH, Jonathan Weber MPH, Jaffar Khan MD, David J. Cohen MD, Andrew Berke MD, Ziad Ali MD DPhil, Omar K. Khalique MD
There are various devices under clinical investigation for transcatheter mitral valve intervention and transcatheter tricuspid valve intervention (TTVI); however, the exclusion rates remain high. We aimed to investigate the exclusion rates for transcatheter mitral valve repair (TMVr), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve repair (TTVr), and transcatheter tricuspid
-
Atrial Fibrillation Amplifies Heart Failure Risk in Anthracycline Treated Cancer Patients: Stacking Risk Factors in the Vulnerable Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Leonard Ilkhanoff MD MS, Brett Atwater MD, Ana Barac MD
-
Transcatheter Intervention for Inoperable Tricuspid Surgical Prosthesis Dysfunction: Minimally Invasive Approach to Mitigate Heart Failure Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-02 Piotr Nikodem Rudziński MD PhD, Jan Henzel MD PhD, Adam Witkowski MD, Maciej Dąbrowski MD PhD, Zenon Huczek MD, Wojciech Wojakowski MD, Radosław Targoński MD PhD, Dariusz Jagielak MD PhD, Paweł Kralisz MD PhD, Marcin Demkow MD
What is the efficacy and safety of transcatheter tricuspid valve-in-valve implantation for patients with inoperable tricuspid surgical prosthesis dysfunction? Thirty-day mortality after greatly effective transcatheter treatment is 2 times less than the estimated surgical risk.
-
The Characteristics of Primary Retrograde Approach Selection for Native Coronary Chronic Occlusion With Short Occlusion Length from the Japanese CTO-PCI Expert Registry Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Yusuke Ochiumi MD, Etsuo Tsuchikane MD PhD, Koichi Kishi MD, Hisayuki Okada MD PhD, Yoshiaki Ito MD, Yuji Oikawa MD, Ryohei Yoshikawa MD, Atsunori Okamura MD PhD, Hiroyuki Tanaka MD, Osamu Katoh MD
Although the coronary chronic total occlusion (CTO) crossing algorithm has been published, the characteristics associated with the first strategy selection for short-length lesions <20 mm is still debatable. This study aimed to determine the characteristics associated with primary retrograde approach (PRA) for native CTO with short occlusion length in percutaneous coronary intervention (PCI).
-
Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Sahib Singh MD, Aakash Garg MD, Udaya S Tantry PhD, Kevin Bliden MBA, Paul A. Gurbel MD, Martha Gulati MD MS
Although the cardiovascular (CV) benefits of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with diabetes mellitus (DM) are well known, their effects in patients without DM continue to be explored. We provide a meta-analysis of the available evidence. Online databases were searched for randomized controlled trials (RCTs) comparing SGLT2i to placebo/control in patients without DM. The
-
Asymptomatic Aortic Stenosis: From Risk Stratification to Treatment Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Marko Banovic MD PhD, Bernard Iung MD PhD, Svetozar Putnik MD PhD, Thabo Mahendiran MD, Marc Vanderheyden MD PhD, Emanuele Barbato MD PhD, Jozef Bartunek MD PhD
Our understanding of the natural history of aortic stenosis has significantly increased over the last decade. There have been considerable advances in the diagnosis and risk stratification of patients with aortic stenosis and in surgical and anesthetic techniques. In addition, transcatheter aortic valve replacement has established itself as a viable alternative to surgical management. Inevitably, these
-
Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Hani Alturkmani MD, Barry Uretsky MD, Swetal Patel MD, Mu'nes Albadaineh MD, Omar Alqaisi MD, Malek Alaiwah MD, Michael Cross MD MA, Danish Abbasi MD, William Rollefson MD
Intravenous unfractionated heparin (UFH) is the most frequently used anticoagulant for percutaneous coronary intervention (PCI). Intravenous enoxaparin, a low-molecular-weight heparin, has superior pharmacokinetic and pharmacodynamic properties compared with UFH. Multiple trials have shown enoxaparin to be safe and effective in PCI. However, there has not been a contemporary study evaluating its safety
-
Associations Between Visceral Fat, Abdominal Muscle, and Coronary Artery Calcification: A Cross-Sectional Analysis of the Multi-Ethnic Study of Atherosclerosis Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Amier Haidar MD MPH, Preethi Srikanthan MD MS, Karol Watson MD PhD, Matthew Allison MD MPH, Richard Kronmal PhD, Tamara Horwich MD MS
The associations of body composition components, including muscle and adipose tissue, and markers of subclinical coronary artery disease are unclear. We examined the relation between abdominal computed tomography (CT)–derived measures of the area and density of fat and muscle with coronary artery calcification (CAC), using data from the Multi-Ethnic Study of Atherosclerosis (MESA). A total of 1,974
-
Low Muscle Mass by Preprocedural Computed Tomography Is Associated With Worse Short-Term Outcomes in Transcatheter Aortic Valve Replacement Recipients Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Ian Persits DO, Saeid Mirzai DO, Kunaal S. Sarnaik BS, Maximilian C. Volk DO, James Yun MD PhD, Serge Harb MD, Rishi Puri MD PhD, Samir Kapadia MD, Amar Krishnaswamy MD, Po-Hao Chen MD MBA, Grant Reed MD, W. H. Wilson Tang MD
Low muscle mass (LMM) is associated with worse outcomes in various clinical situations. Traditional frailty markers have been used for preoperative risk stratification in patients who underwent transcatheter aortic valve replacement (TAVR). However, preoperative imaging provides an opportunity to directly quantify skeletal muscle mass to identify patients at higher risk of procedural complications
-
Association Between Atrial Fibrillation Symptoms and Clinical Outcomes: A Prospective Multicenter Registry Study Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Sang Jun Lee MD, Junbeom Park MD PhD, Jin-Kyu Park MD PhD, Ki-Woon Kang MD PhD, Jaemin Shim MD PhD, Eue-Keun Choi MD PhD, Jun Kim MD PhD, Jin-Bae Kim MD PhD, Young Soo Lee MD PhD, Hyung Wook Park MD PhD, Boyoung Joung MD PhD
The presence of symptoms plays an important role in determining whether to focus on rhythm control or rate control when treating atrial fibrillation (AF). Previous comparative studies on the clinical outcomes of symptomatic and asymptomatic AF have yielded inconsistent results, and a link between AF symptoms and left atrial (LA) remodeling is not established. Patients selected from the COmparison study
-
Changes in Global Longitudinal Strain as a Predictor of Cardiotoxicity After Exposure to Carfilzomib Am. J. Cardiol. (IF 2.8) Pub Date : 2024-03-01 Ranbir Singh MD, Dylan Sperling MD, Anthony Delicce MD, Sophia Golec MD, Supreet Singh MD, Nicole Zatorski PhD, Solomon Bienstock MD, Sumeet Singh Mitter MD MSc, Stamatios Lerakis MD, Gagan D. Sahni MD
-
Percutaneous Coronary Intervention in Nonagenarians Presenting With an Acute Coronary Syndrome Am. J. Cardiol. (IF 2.8) Pub Date : 2024-02-29 Gjin Ndrepepa MD